Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Vamikibart in Participants With Uveitic Macular Edema

ClinicalTrials.gov ID: NCT05642325

Public ClinicalTrials.gov record NCT05642325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema

Study identification

NCT ID
NCT05642325
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
256 participants

Conditions and interventions

Interventions

  • Sham Other
  • Vamikibart Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2023
Primary completion
May 6, 2025
Completion
Dec 23, 2025
Last update posted
Apr 16, 2026

2023 – 2025

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
Associated Retina Consultants Phoenix Arizona 85020
Barnet Dulaney Perkins Eye Center Sun City Arizona 85351
Retina Consultants of Orange County Fullerton California 92835
Northern California Retina Vitreous Associates Mountain View California 94040
California Eye Specialists Medical group Inc. Pasadena California 91107
Retina Consultants of Southern California Redlands California 92374
Kaiser Permanente Riverside Medical Center Riverside California 92505
University of California, Davis, Eye Center Sacramento California 95817
Retinal Consultants Med Group Sacramento California 95825
Advanced Research Deerfield Beach Florida 33064
Retina Group of Florida Fort Lauderdale Florida 33308
University Retina and Macula Associates, PC Oak Forest Illinois 60452
Cumberland Valley Retina PC Hagerstown Maryland 21740
University of Michigan, Kellogg Eye Center Ann Arbor Michigan 48105
Duke Eye Center Durham North Carolina 27710
Cleveland Clinic Cleveland Ohio 44195
Erie Retina Research Erie Pennsylvania 16507-1429
Mid Atlantic Retina Philadelphia Pennsylvania 19107
Retina Research Institute of Texas Abilene Texas 79606
Retina Consultants of Texas Bellaire Texas 77401
Retina Consultants of Texas Katy Texas 77494
Retina Group of Washington Fairfax Virginia 22031
University of Wisconsin Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05642325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05642325 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →